BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND FGFR1OP, FOP, 11116, ENSG00000213066
15 results:

  • 1. [The mediating effect of coping style between illness perception and fear of cancer recurrence in patients undergoing radical prostatectomy].
    Yan QQ; Yao X; Liu YC; Zhou JR; Cai J; Wu ZG; Jiang HH; Li HY
    Zhonghua Nan Ke Xue; 2023 Jun; 29(6):511-517. PubMed ID: 38602723
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Coping strategies mediate the relationship between fear of cancer recurrence and quality of life in postoperative patients with prostate cancer: a multicentre survey.
    Yu C; Jingzhen Z; Luqiang Z; Xiaojuan Y; Ji Z
    BMC Urol; 2024 Mar; 24(1):49. PubMed ID: 38429701
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Couples coping with advanced prostate cancer: an explorative study on decision-making preferences, self-efficacy and fear of progression.
    Bugaj TJ; Maatouk I; Hanslmeier T; Zschäbitz S; Huber J; Flock C; Friederich HC; Ihrig A
    World J Urol; 2023 Apr; 41(4):1041-1046. PubMed ID: 36810686
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Health-related quality of life of advanced prostate cancer patients and spouses: results from actor-partner interdependence models.
    Sauer C; Ihrig A; Hanslmeier T; Huber J; Hiller K; Friederich HC; Maatouk I
    Support Care Cancer; 2022 Aug; 30(8):6985-6993. PubMed ID: 35556168
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Decreased mental health, quality of life, and utilization of professional help in cancer patients with unexpressed needs: A longitudinal analysis.
    Heß V; Meng K; Schulte T; Neuderth S; Bengel J; Faller H; Schuler M
    Psychooncology; 2022 May; 31(5):725-734. PubMed ID: 34841641
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [The Impact of Health literacy on Health Outcomes in cancer Patients Attending Inpatient Rehabilitation].
    Meng K; Heß V; Schulte T; Faller H; Schuler M
    Rehabilitation (Stuttg); 2021 Apr; 60(2):102-109. PubMed ID: 33858019
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1.
    Ma XX; Cao ZG; Zhao SL
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3565-3571. PubMed ID: 32329830
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Quality of life and fear of disease progression are associated with aspects of health literacy in men with prostate cancer from Germany.
    Haack M; Kramer S; Seidel G; Dierks ML
    Support Care Cancer; 2020 May; 28(5):2283-2292. PubMed ID: 31473840
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Fear of cancer recurrence across the survivorship trajectory: Results from a survey of adult long-term cancer survivors.
    Götze H; Taubenheim S; Dietz A; Lordick F; Mehnert-Theuerkauf A
    Psychooncology; 2019 Oct; 28(10):2033-2041. PubMed ID: 31364222
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Knockdown of the long noncoding RNA HOTTIP inhibits cell proliferation and enhances cell sensitivity to cisplatin by suppressing the Wnt/β-catenin pathway in prostate cancer.
    Jiang H; Xiong W; Chen L; Lv Z; Yang C; Li Y
    J Cell Biochem; 2019 Jun; 120(6):8965-8974. PubMed ID: 30809864
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. miR-1301-3p promotes prostate cancer stem cell expansion by targeting SFRP1 and GSK3β.
    Song XL; Huang B; Zhou BW; Wang C; Liao ZW; Yu Y; Zhao SC
    Biomed Pharmacother; 2018 Mar; 99():369-374. PubMed ID: 29358129
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Fear of recurrence in long-term cancer survivors-Do cancer type, sex, time since diagnosis, and social support matter?
    Koch-Gallenkamp L; Bertram H; Eberle A; Holleczek B; Schmid-Höpfner S; Waldmann A; Zeissig SR; Brenner H; Arndt V
    Health Psychol; 2016 Dec; 35(12):1329-1333. PubMed ID: 27175578
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Fear of progression in patients 6 months after cancer rehabilitation-a- validation study of the fear of progression questionnaire fop-Q-12.
    Hinz A; Mehnert A; Ernst J; Herschbach P; Schulte T
    Support Care Cancer; 2015 Jun; 23(6):1579-87. PubMed ID: 25412727
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Fear of progression in partners of chronically ill patients.
    Zimmermann T; Herschbach P; Wessarges M; Heinrichs N
    Behav Med; 2011 Jul; 37(3):95-104. PubMed ID: 21895427
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Gene therapy approach in prostate cancer cells using an active Wnt signal.
    Giladi N; Dvory-Sobol H; Sagiv E; Kazanov D; Liberman E; Arber N
    Biomed Pharmacother; 2007 Oct; 61(9):527-30. PubMed ID: 17904788
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.